Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 1.000

-0.7%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mitchell A. Blass, M.D. who wrote (9834)	7/22/1998 2:54:00 PM
From: Scott H. Davis	Read Replies (1) of 14328

Looked at the report & its a mixed bag. On the + side, costs of move are stated to be over, good cash & the guys finally released more detail in their statements (cost of goods sold, administrative) and the lack of > coupled with the increase in revenues is VERY POSITIVE. Year over year EPS was great again, and the sequential qtr trend is lousy (.02, .02, .02). The great year over year comps end qtr4 98 unless TRIBY grows revenue and cools it with the shares QUICKLY. I know some individualls are tired of my talking about it & publically don't seem to care, but shares outstanding increased significantly again - 7.26% more shares - still adding paper at near 30% clip, just like last year. Current ratio is still pretty anemic at 2:1 for anybody using a value criteria. IMSCO Scott (kinda funny, the one now labeled as arrogant is the only person who ends most posts with a self-effacing acrynonym - In My Semi-Clueless Opinion)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next